cdmo.directory
← Compare landing

Altasciences vs Lonza Cell & Gene Technologies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/altasciences/lonza

CategoryAltasciencesLonza Cell & Gene Technologies
Listed sitebothcdmo
SummaryMid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.Lonza is the world's leading CDMO, founded in Switzerland in 1897, serving the healthcare industry with integrated offerings for contract development and manufacturing of therapies across multiple modalities.
Services
  • Preclinical In Vivo Studies
  • GLP Toxicology
  • Safety Pharmacology
  • In Vitro Pharmacology
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Clinical Trial Services
  • Bioanalysis
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Medical Writing
  • Clinical Operations
  • Regulatory Affairs
  • In Vivo PK / PD Studies
  • Preclinical In Vitro Studies
  • Phase IV / Post-Marketing
  • In Vitro ADME / DMPK
  • Formulation Development
  • Stability Testing & Storage
  • Cell-Line Development
  • Protein Engineering
  • Analytical Method Development & Validation
  • Process Development
  • Formulation Development
  • Technology Transfer
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Regulatory Affairs
  • Cell Therapy Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Quality Control Testing
  • Microbiology Services
  • Translational Research
  • CMC Analytical Development
  • Stability Testing & Storage
Modalities
  • Small Molecule
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
Indications
  • Cardiovascular
  • Dermatology
  • Gastroenterology
  • Immunology
  • Infectious Disease
  • Metabolic
  • Neurology
  • Oncology
  • Ophthalmology
  • Psychiatry
  • Respiratory
  • Women's Health
Data not yet provided.
Locations
  • Headquarters, Montreal, Quebec, Canada
  • Bioanalytical Laboratory, Laval, Quebec, Canada
  • Clinical Site, Montreal, Quebec, Canada
  • Clinical and Research Campus, Overland Park, Kansas, United States
  • Preclinical Testing, Everett, Washington, United States
  • Manufacturing and Analytical Services, Harleysville, Pennsylvania, United States
  • Preclinical Testing, Scranton, Pennsylvania, United States
  • Preclinical Testing, Columbia, Missouri, United States
  • Clinical Pharmacology, Cypress, California, United States
  • Preclinical Testing, Sacramento, California, United States
  • Laval, Laval, Quebec, Canada
  • Overland Park, Overland Park, Kansas, United States
  • Everett, Everett, Washington, United States
  • Harleysville, Harleysville, Pennsylvania, United States
  • Cypress, Cypress, California, United States
  • Scott Township, Scott Township, Pennsylvania, United States
  • Auxvasse, Auxvasse, Missouri, United States
  • Sacramento, Sacramento, California, United States
  • Canada, Canada, Canada
  • United States, United States, United States
  • Canada and U.S. operations
  • Headquarters, Basel, Basel-Stadt, Switzerland
Certifications
  • FDA · Identifier: FDA inspection passed 2001
  • GLP · Identifier: GLP Compliant
  • GMP · Identifier: GMP Manufacturing
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.